Uthever® NMN NOVEL FOOD Update Download Whitepaper

Overview


EFFEPHARM

NMN is a precursor to NAD+. NAD+ is crucial for energy production, DNA repair, and regulating various cellular processes.

Uthever® NMN, the world’s first large-scale, human clinically-proven NMN brand, has completed the EU NOVEL FOOD Public Consultation. Uthever® is pioneering the EU NOVEL FOOD application process as the first NMN brand to enter the risk assessment stage and is now pending approval. Contact us to plan ahead and get your product market-ready.

Download the whitepaper for industry insights, the latest scientific findings on NMN, and comprehensive global regulatory information.

This content is provided by Effepharm Ltd, and any views and opinions expressed do not necessarily reflect those of NutraIngredients.com

Download Now


Latest Content

Related Resources

Official: Uthever® NMN Secures FDA NDI Clearance

Official: Uthever® NMN Secures FDA NDI Clearance

Content provided by Effepharm Ltd

White Paper

Why choose Uthever®? Stronger compliance: Uthever® has secured an FDA NDI notification (NDI 1267), confirming the compliance of its NMN ingredient.

Supplier Info Centre

Effepharm-Ltd.jpg

For more product information visit Effepharm Ltd.